Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer - Henderson, I C; Berry, D A; Demetri, G D; Cirrincione, C T; Goldstein, L J; Martino, S (J Clin Oncol, 2003)